Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Fevertree Share News (FEVR)
FEVR Share
Price
FEVR Share
News
FEVR Share
Chat
FEVR Share
Trades816
FEVR
Live RNS1
FEVR Share
Charts
FEVR Level 2
Console
FEVR Live
Share Price
FEVR Broker
Ratings
FEVR Directors
Deals
FEVR Financial
Diary
FEVR
Fundamentals
FEVR Short
Positions2
FEVR
Media
FEVR Company
Research
FEVR Company
Timeline3
Share Price Information for Fevertree (FEVR)
Last checked at -
Last checked at 
Intraday Fevertree Share Chart
AGM, EGM Calendar - Week Ahead
| UK AGM, EGM Calendar |
| Wednesday, May 6 |
| National Express |
| 4imprint |
| Carillion |
| Tullett Prebon |
| Costain |
| Howden Joinery |
| Medaphor |
| Amerisur Resources |
| Inmarsat |
| Intu Properties |
| Serco |
| Standard Chartered |
| BHP Billiton |
| Gulf Marine Services |
| Deltex Medical |
| Thursday, May 7 |
| Glencore |
| CRH |
| GKN |
| IMI |
| Millennium & Copthorne Hotels |
| BAE Systems |
| Provident Financial Group |
| William Hill |
| GlaxoSmithKline |
| Ladbrokes |
| Gresham Computing |
| Rightmove |
| BrainJuicer |
| Charles Taylor |
| Kaz Minerals |
| Morgan Sindall |
| Reckitt Benckiser |
| Communisis |
| Trinity Mirror |
| Alent |
| Oxford Biomedica |
| Fevertree Drinks |
| Friday, May 8 |
| Laird |
| Pendragon |
| Rolls Royce |
| Clarkson |
| Man Group |
| BBA Aviation |
| Morgan Advanced Materials |
| RSA Insurance |
| T Clarke |
| IHG |
| John Laing Infrastructure |
| Monday, May 11 |
| Spirax-Sarco |
| European Real Estate |
| Mirland Development |
| Tuesday, May 12 |
| Al-Noor Hospitals |
| British Polythene Industries |
| Vitec |
| Standard Life |
| Lamprell |
| Capita |
| Interserve |
| Hilton Food Group |
| Glanbia |
| Grafton Group |
| TT Electronics |
| IP Group |
| Sportech |
| Cape |
| Clean Air Power |
| Cello |
| Skyepharma |
| Capital & Regional |
| Copyright 2015 Alliance News Limited. All Rights Reserved. |
Latest FEVR News
- IN BRIEF: Fevertree Drinks starts GBP30 million buyback extension
1 Jul 2026 - UK dividends calendar - next 7 days
19 Jun 2026 - UK's FTSE 100 hits over three-week low as banks, energy stocks sag
9 Jun 2026 - Fevertree Drinks extends share buyback after solid start to year
9 Jun 2026 - Fever-Tree toasts strong start to the year, shares fizz
9 Jun 2026 - LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
9 Jun 2026 - UK shareholder meetings calendar - next 7 days
2 Jun 2026 - UK dividends calendar - next 7 days
14 May 2026
Related News
Bank of England sets out plan to ease bank leverage rules
* BoE sets out plan to ease leverage ratio requirements and enhance buffer usability
WINNERS & LOSERS: Beauty Tech ups guidance; Ixico to beat expectations
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Capita issues apology on missed deadline on civil service pensions
(Alliance News) - Capita PLC on Tuesday apologised for distress and inconvenience after the company missed a ministerial deadline on civil service pen...
Fevertree News
IN BRIEF: Fevertree Drinks starts GBP30 million buyback extension
Fevertree Drinks PLC - London-based maker of premium drink mixers - Fevertree starts the GBP30 million extension of its share buyback programme, which...
UK's FTSE 100 hits over three-week low as banks, energy stocks sag
June 9 (Reuters) - Britain's blue-chip FTSE 100 hit its lowest since mid-May on Tuesday, bogged down by losses in heavyweight lenders HSBC and Stan...
Fevertree Drinks extends share buyback after solid start to year
(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of ...
Fever-Tree toasts strong start to the year, shares fizz
(Sharecast News) - Shares in Fever-Tree Drinks fizzed on Tuesday, after the British business reaffirmed its full-year outlook and extended its share b...
LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...
Follow the stocks
